Acute Bipolar Manic Episode
Conditions
Keywords
Patients admitted as for an acute bipolar manic episode, Description of management patterns and hospital stay in patients admitted for acute bipolar manic episode and treated with either quetiapine IR or quetiapine XR
Brief summary
This study is being carried out to find out how patients suffering from the acute manic phase of bipolar disease are currently managed with Quetiapine Immediate Release (IR) or Quetiapine Extended Release (XR) in the hospital setting in real life practice, including length of stay.
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients diagnosed with Bipolar Disorder (ICD-10). * Admitted for acute bipolar manic episode from 1st October 2009 to 1st October 2010 * Patients treated with quetiapine IR or quetiapine XR during the hospitalization period.
Exclusion criteria
* Patients in which BD is not the main reason for hospitalization * Patients admitted for acute bipolar mania episodes but finally diagnosed with mixed or bipolar disorder not otherwise specified (NOS) episodes * Patients receiving both quetiapine IR and XR during the same hospitalization period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length of hospital stay | — |
Secondary
| Measure | Time frame |
|---|---|
| Use of resources | — |
| Treatments used | — |
| Demographics | — |
Countries
Belgium, Croatia, Denmark, Finland, Germany, Italy, Turkey (Türkiye), United Kingdom
Outcome results
None listed